Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Diabetic Therapeutic Drugs market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Diabetic Therapeutic Drugsmarket, defines the market attractiveness level of Diabetic Therapeutic Drugs market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Diabetic Therapeutic Drugs industry, describes the types of Diabetic Therapeutic Drugs market, the applications of major players and the market size, and deeply analyzes the current situation of the global Diabetic Therapeutic Drugs market and the development prospects and opportunities of Diabetic Therapeutic Drugs industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Diabetic Therapeutic Drugs market in Chapter 13.
By Player:
AstraZeneca
Takeda Pharmaceuticals
Mitsubishi Tanabe Pharma
Perle Biosciences
Novartis
Eisai
Eli Lilly
Arbutus Biopharma
Belrose Pharma
Sun Pharma
Dong-A ST
Merck
Pfizer
Sanofi
Novo Nordisk
By Type:
Insulin Therapies
Non-Insulin Therapies
By End-User:
Type 1 Diabetes
Type 2 Diabetes
Gestational Diabetes
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Diabetic Therapeutic Drugs Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Diabetic Therapeutic Drugs Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Diabetic Therapeutic Drugs Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Diabetic Therapeutic Drugs Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Diabetic Therapeutic Drugs Market Analysis and Outlook to 2022
-
7.1 Global Diabetic Therapeutic Drugs Consumption (2017-2022)
-
7.2 United States Diabetic Therapeutic Drugs Consumption (2017-2022)
-
7.3 Europe Diabetic Therapeutic Drugs Consumption (2017-2022)
-
7.4 China Diabetic Therapeutic Drugs Consumption (2017-2022)
-
7.5 Japan Diabetic Therapeutic Drugs Consumption (2017-2022)
-
7.6 India Diabetic Therapeutic Drugs Consumption (2017-2022)
-
7.7 South Korea Diabetic Therapeutic Drugs Consumption (2017-2022)
8 Region and Country-wise Diabetic Therapeutic Drugs Market Analysis and Outlook to 2028
-
8.1 Global Diabetic Therapeutic Drugs Consumption Forecast (2022-2028)
-
8.2 United States Diabetic Therapeutic Drugs Consumption Forecast (2022-2028)
-
8.3 Europe Diabetic Therapeutic Drugs Consumption Forecast (2022-2028)
-
8.4 China Diabetic Therapeutic Drugs Consumption Forecast (2022-2028)
-
8.5 Japan Diabetic Therapeutic Drugs Consumption Forecast (2022-2028)
-
8.6 India Diabetic Therapeutic Drugs Consumption Forecast (2022-2028)
-
8.7 South Korea Diabetic Therapeutic Drugs Consumption Forecast (2022-2028)
9 Global Diabetic Therapeutic Drugs Market Outlook by Types and Applications to 2022
-
9.1 Global Diabetic Therapeutic Drugs Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Insulin Therapies Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Non-Insulin Therapies Consumption and Growth Rate (2017-2022)
-
9.2 Global Diabetic Therapeutic Drugs Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Type 1 Diabetes Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Type 2 Diabetes Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Gestational Diabetes Consumption and Growth Rate (2017-2022)
10 Global Diabetic Therapeutic Drugs Market Outlook by Types and Applications to 2028
-
10.1 Global Diabetic Therapeutic Drugs Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Insulin Therapies Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Non-Insulin Therapies Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Diabetic Therapeutic Drugs Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Type 1 Diabetes Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Type 2 Diabetes Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Gestational Diabetes Consumption Forecast and Growth Rate (2022-2028)
11 Global Diabetic Therapeutic Drugs Import and Export Analysis (Top 5 Countries)
-
11.1 Global Diabetic Therapeutic Drugs Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Diabetic Therapeutic Drugs Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Diabetic Therapeutic Drugs Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Diabetic Therapeutic Drugs Market Competitive Analysis
-
14.1 AstraZeneca
-
14.1.1 AstraZeneca Company Details
-
14.1.2 AstraZeneca Diabetic Therapeutic Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 AstraZeneca Diabetic Therapeutic Drugs Product and Service
-
14.2 Takeda Pharmaceuticals
-
14.2.1 Takeda Pharmaceuticals Company Details
-
14.2.2 Takeda Pharmaceuticals Diabetic Therapeutic Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Takeda Pharmaceuticals Diabetic Therapeutic Drugs Product and Service
-
14.3 Mitsubishi Tanabe Pharma
-
14.3.1 Mitsubishi Tanabe Pharma Company Details
-
14.3.2 Mitsubishi Tanabe Pharma Diabetic Therapeutic Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Mitsubishi Tanabe Pharma Diabetic Therapeutic Drugs Product and Service
-
14.4 Perle Biosciences
-
14.4.1 Perle Biosciences Company Details
-
14.4.2 Perle Biosciences Diabetic Therapeutic Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Perle Biosciences Diabetic Therapeutic Drugs Product and Service
-
14.5 Novartis
-
14.5.1 Novartis Company Details
-
14.5.2 Novartis Diabetic Therapeutic Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Novartis Diabetic Therapeutic Drugs Product and Service
-
14.6 Eisai
-
14.6.1 Eisai Company Details
-
14.6.2 Eisai Diabetic Therapeutic Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Eisai Diabetic Therapeutic Drugs Product and Service
-
14.7 Eli Lilly
-
14.7.1 Eli Lilly Company Details
-
14.7.2 Eli Lilly Diabetic Therapeutic Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Eli Lilly Diabetic Therapeutic Drugs Product and Service
-
14.8 Arbutus Biopharma
-
14.8.1 Arbutus Biopharma Company Details
-
14.8.2 Arbutus Biopharma Diabetic Therapeutic Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Arbutus Biopharma Diabetic Therapeutic Drugs Product and Service
-
14.9 Belrose Pharma
-
14.9.1 Belrose Pharma Company Details
-
14.9.2 Belrose Pharma Diabetic Therapeutic Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Belrose Pharma Diabetic Therapeutic Drugs Product and Service
-
14.10 Sun Pharma
-
14.10.1 Sun Pharma Company Details
-
14.10.2 Sun Pharma Diabetic Therapeutic Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 Sun Pharma Diabetic Therapeutic Drugs Product and Service
-
14.11 Dong-A ST
-
14.11.1 Dong-A ST Company Details
-
14.11.2 Dong-A ST Diabetic Therapeutic Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.11.3 Dong-A ST Diabetic Therapeutic Drugs Product and Service
-
14.12 Merck
-
14.12.1 Merck Company Details
-
14.12.2 Merck Diabetic Therapeutic Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.12.3 Merck Diabetic Therapeutic Drugs Product and Service
-
14.13 Pfizer
-
14.13.1 Pfizer Company Details
-
14.13.2 Pfizer Diabetic Therapeutic Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.13.3 Pfizer Diabetic Therapeutic Drugs Product and Service
-
14.14 Sanofi
-
14.14.1 Sanofi Company Details
-
14.14.2 Sanofi Diabetic Therapeutic Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.14.3 Sanofi Diabetic Therapeutic Drugs Product and Service
-
14.15 Novo Nordisk
-
14.15.1 Novo Nordisk Company Details
-
14.15.2 Novo Nordisk Diabetic Therapeutic Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.15.3 Novo Nordisk Diabetic Therapeutic Drugs Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Diabetic Therapeutic Drugs
-
Figure Diabetic Therapeutic Drugs Picture
-
Table Global Diabetic Therapeutic Drugs Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Diabetic Therapeutic Drugs Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Diabetic Therapeutic Drugs Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Diabetic Therapeutic Drugs Consumption by Country (2017-2022)
-
Figure United States Diabetic Therapeutic Drugs Consumption and Growth Rate (2017-2022)
-
Table Europe Diabetic Therapeutic Drugs Consumption and Growth Rate (2017-2022)
-
Figure China Diabetic Therapeutic Drugs Consumption and Growth Rate (2017-2022)
-
Figure Japan Diabetic Therapeutic Drugs Consumption and Growth Rate (2017-2022)
-
Figure India Diabetic Therapeutic Drugs Consumption and Growth Rate (2017-2022)
-
Figure South Korea Diabetic Therapeutic Drugs Consumption and Growth Rate (2017-2022)
-
Figure Global Diabetic Therapeutic Drugs Consumption Forecast by Country (2022-2028)
-
Figure United States Diabetic Therapeutic Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Diabetic Therapeutic Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Diabetic Therapeutic Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Diabetic Therapeutic Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Diabetic Therapeutic Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Diabetic Therapeutic Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Insulin Therapies Consumption and Growth Rate (2017-2022)
-
Figure Global Non-Insulin Therapies Consumption and Growth Rate (2017-2022)
-
Figure Global Type 1 Diabetes Consumption and Growth Rate (2017-2022)
-
Figure Global Type 2 Diabetes Consumption and Growth Rate (2017-2022)
-
Figure Global Gestational Diabetes Consumption and Growth Rate (2017-2022)
-
Figure Global Insulin Therapies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Non-Insulin Therapies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Type 1 Diabetes Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Type 2 Diabetes Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Gestational Diabetes Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Diabetic Therapeutic Drugs Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Diabetic Therapeutic Drugs Export by Region (Top 5 Countries) (2017-2028)
-
Table AstraZeneca (Foundation Year, Company Profile and etc.)
-
Table AstraZeneca Diabetic Therapeutic Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table AstraZeneca Diabetic Therapeutic Drugs Product and Service
-
Table Takeda Pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table Takeda Pharmaceuticals Diabetic Therapeutic Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Takeda Pharmaceuticals Diabetic Therapeutic Drugs Product and Service
-
Table Mitsubishi Tanabe Pharma (Foundation Year, Company Profile and etc.)
-
Table Mitsubishi Tanabe Pharma Diabetic Therapeutic Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Mitsubishi Tanabe Pharma Diabetic Therapeutic Drugs Product and Service
-
Table Perle Biosciences (Foundation Year, Company Profile and etc.)
-
Table Perle Biosciences Diabetic Therapeutic Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Perle Biosciences Diabetic Therapeutic Drugs Product and Service
-
Table Novartis (Foundation Year, Company Profile and etc.)
-
Table Novartis Diabetic Therapeutic Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis Diabetic Therapeutic Drugs Product and Service
-
Table Eisai (Foundation Year, Company Profile and etc.)
-
Table Eisai Diabetic Therapeutic Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Eisai Diabetic Therapeutic Drugs Product and Service
-
Table Eli Lilly (Foundation Year, Company Profile and etc.)
-
Table Eli Lilly Diabetic Therapeutic Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Eli Lilly Diabetic Therapeutic Drugs Product and Service
-
Table Arbutus Biopharma (Foundation Year, Company Profile and etc.)
-
Table Arbutus Biopharma Diabetic Therapeutic Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Arbutus Biopharma Diabetic Therapeutic Drugs Product and Service
-
Table Belrose Pharma (Foundation Year, Company Profile and etc.)
-
Table Belrose Pharma Diabetic Therapeutic Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Belrose Pharma Diabetic Therapeutic Drugs Product and Service
-
Table Sun Pharma (Foundation Year, Company Profile and etc.)
-
Table Sun Pharma Diabetic Therapeutic Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sun Pharma Diabetic Therapeutic Drugs Product and Service
-
Table Dong-A ST (Foundation Year, Company Profile and etc.)
-
Table Dong-A ST Diabetic Therapeutic Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Dong-A ST Diabetic Therapeutic Drugs Product and Service
-
Table Merck (Foundation Year, Company Profile and etc.)
-
Table Merck Diabetic Therapeutic Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Merck Diabetic Therapeutic Drugs Product and Service
-
Table Pfizer (Foundation Year, Company Profile and etc.)
-
Table Pfizer Diabetic Therapeutic Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Diabetic Therapeutic Drugs Product and Service
-
Table Sanofi (Foundation Year, Company Profile and etc.)
-
Table Sanofi Diabetic Therapeutic Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sanofi Diabetic Therapeutic Drugs Product and Service
-
Table Novo Nordisk (Foundation Year, Company Profile and etc.)
-
Table Novo Nordisk Diabetic Therapeutic Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novo Nordisk Diabetic Therapeutic Drugs Product and Service
-
